研究使用Ethos生成的癌症头颈部患者治疗计划的可行性。

Q1 Nursing
Adam El-qmache, John McLellan
{"title":"研究使用Ethos生成的癌症头颈部患者治疗计划的可行性。","authors":"Adam El-qmache,&nbsp;John McLellan","doi":"10.1016/j.tipsro.2023.100216","DOIUrl":null,"url":null,"abstract":"<div><p>The Varian Ethos treatment platform is designed to automatically create complex RT treatment plans, reducing both workload and operator variability in plan quality. The aim of this study is to evaluate the quality of Ethos-generated head and neck (H&amp;N) treatment plans.</p><p>Ethos plans were created for ten previous H&amp;N patients and these were compared with the original clinical plans generated in Eclipse. Ethos automatically creates several plans with different field arrangements for each patient. All plans were compared quantitatively using: dose-volume metrics; dose conformity; dose heterogeneity and monitor units (MU). In addition, two H&amp;N Oncologists assessed the clinical acceptability of the Ethos plans.</p><p>Consultant 1 judged there to be at least three clinically acceptable Ethos plans for 9 out of 10 patients reviewed. Consultant 2 approved of at least two Ethos plans for 5 out of 5 patients reviewed. The Ethos plans’ average dose metrics were comparable to the clinical plans. The average plan MU was similar for Eclipse and Ethos VMAT plans. The average plan MU for Ethos IMRT plans was larger with respect to all VMAT plans.</p><p>The Ethos Treatment Planning system is capable of automatically creating good quality treatment plans for a range of H&amp;N cancer patients.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/d6/main.PMC10511846.pdf","citationCount":"0","resultStr":"{\"title\":\"Investigating the feasibility of using Ethos generated treatment plans for head and neck cancer patients\",\"authors\":\"Adam El-qmache,&nbsp;John McLellan\",\"doi\":\"10.1016/j.tipsro.2023.100216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The Varian Ethos treatment platform is designed to automatically create complex RT treatment plans, reducing both workload and operator variability in plan quality. The aim of this study is to evaluate the quality of Ethos-generated head and neck (H&amp;N) treatment plans.</p><p>Ethos plans were created for ten previous H&amp;N patients and these were compared with the original clinical plans generated in Eclipse. Ethos automatically creates several plans with different field arrangements for each patient. All plans were compared quantitatively using: dose-volume metrics; dose conformity; dose heterogeneity and monitor units (MU). In addition, two H&amp;N Oncologists assessed the clinical acceptability of the Ethos plans.</p><p>Consultant 1 judged there to be at least three clinically acceptable Ethos plans for 9 out of 10 patients reviewed. Consultant 2 approved of at least two Ethos plans for 5 out of 5 patients reviewed. The Ethos plans’ average dose metrics were comparable to the clinical plans. The average plan MU was similar for Eclipse and Ethos VMAT plans. The average plan MU for Ethos IMRT plans was larger with respect to all VMAT plans.</p><p>The Ethos Treatment Planning system is capable of automatically creating good quality treatment plans for a range of H&amp;N cancer patients.</p></div>\",\"PeriodicalId\":36328,\"journal\":{\"name\":\"Technical Innovations and Patient Support in Radiation Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/d6/main.PMC10511846.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Technical Innovations and Patient Support in Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405632423000161\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technical Innovations and Patient Support in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405632423000161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

摘要

Varian Ethos治疗平台旨在自动创建复杂的RT治疗计划,减少工作量和操作员在计划质量方面的可变性。本研究的目的是评估Ethos生成的头颈部(H&N)治疗计划的质量。为之前的10名H&N患者创建了Ethos计划,并将其与Eclipse中生成的原始临床计划进行了比较。Ethos会自动为每位患者创建多个具有不同现场安排的计划。所有方案均使用以下指标进行定量比较:剂量-体积指标;剂量一致性;剂量异质性和监测单位(MU)。此外,两名H&N肿瘤学家评估了Ethos计划的临床可接受性。顾问1判断,在审查的10名患者中,有9名患者至少有三项临床可接受的Ethos计划。顾问2批准了至少两个Ethos计划,适用于审查的5名患者中的5名。Ethos计划的平均剂量指标与临床计划相当。Eclipse和Ethos VMAT计划的平均MU计划相似。Ethos IMRT计划的平均计划MU比所有VMAT计划都要大。Ethos治疗计划系统能够自动为一系列H&N癌症患者创建高质量的治疗计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Investigating the feasibility of using Ethos generated treatment plans for head and neck cancer patients

Investigating the feasibility of using Ethos generated treatment plans for head and neck cancer patients

The Varian Ethos treatment platform is designed to automatically create complex RT treatment plans, reducing both workload and operator variability in plan quality. The aim of this study is to evaluate the quality of Ethos-generated head and neck (H&N) treatment plans.

Ethos plans were created for ten previous H&N patients and these were compared with the original clinical plans generated in Eclipse. Ethos automatically creates several plans with different field arrangements for each patient. All plans were compared quantitatively using: dose-volume metrics; dose conformity; dose heterogeneity and monitor units (MU). In addition, two H&N Oncologists assessed the clinical acceptability of the Ethos plans.

Consultant 1 judged there to be at least three clinically acceptable Ethos plans for 9 out of 10 patients reviewed. Consultant 2 approved of at least two Ethos plans for 5 out of 5 patients reviewed. The Ethos plans’ average dose metrics were comparable to the clinical plans. The average plan MU was similar for Eclipse and Ethos VMAT plans. The average plan MU for Ethos IMRT plans was larger with respect to all VMAT plans.

The Ethos Treatment Planning system is capable of automatically creating good quality treatment plans for a range of H&N cancer patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
48
审稿时长
67 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信